Hey, this is Mike from Amplion. In this video, I’ll provide a quick overview of how you can get more return on your investment in conferences. I’ll show you how to identify relevant contacts for the conference you’re attending and set up meetings in...
Major European pharmaceutical companies are conducting extensive preclinical research to identify and validate new drug targets and biomarkers across various cancer types. This early stage research is crucial to inform clinical development of novel oncology therapies....
Exciting oncology research is underway at several emerging European biopharmaceutical firms. Advances in cancer immunotherapies, antibody-drug conjugates, and combination therapies are highlighted in recent disclosures from these companies targeting both solid tumors...
Cancer remains one of the leading causes of death globally, with an estimated 10 million cancer deaths in 2020 alone. Major European pharmaceutical companies are continuously conducting clinical trials to develop innovative new cancer treatments and improve patient...
So far this year, Amplion has tracked 67 Seed and Series A investments into early-stage biotechs – down from 92 or a 27% decrease during the same period last year. That said, the biotech sector continues to witness rapid advancements, with numerous early-stage...
The research conducted by Pharma orgs across the globe in the field of gene therapy has brought forth significant advancements and potential benefits for patients with various genetic disorders and diseases. These pharmaceutical companies have contributed to expanding...
